WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H556219
CAS#: 4734-59-2
Description: J 3-54, also known as LSD1-IN-24, is a selective LSD1 inhibitor with IC50 = 0.247 μM. J-3-54 can mediate the expression of programmed cell death-ligand 1 (PD-L1), enhance T cell killing response, and can be used in cancer research.
Hodoodo Cat#: H556219
Name: J 3-54
CAS#: 4734-59-2
Chemical Formula: C18H20N2OS
Exact Mass: 312.13
Molecular Weight: 312.430
Elemental Analysis: C, 69.20; H, 6.45; N, 8.97; O, 5.12; S, 10.26
Synonym: LSD1-IN-24; J 3-54; J-3-54; J3-54; J 354; J-354; J354; J 3-54;
IUPAC/Chemical Name: 4-(2-(10H-phenothiazin-10-yl)ethyl)morpholine
InChi Key: VJQXIWLVJMDRGV-UHFFFAOYSA-N
InChi Code: InChI=1S/C18H20N2OS/c1-3-7-17-15(5-1)20(10-9-19-11-13-21-14-12-19)16-6-2-4-8-18(16)22-17/h1-8H,9-14H2
SMILES Code: N1(CCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CCOCC1
Appearance: To be determined
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 312.43 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
